| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 06/08/2022 | 65.29% | B of A Securities | $12 → $4 | Downgrades | Buy → Neutral |
| 10/19/2021 | 395.87% | HC Wainwright & Co. | $19 → $12 | Maintains | Buy |
| 10/08/2021 | — | JP Morgan | Downgrades | Neutral → Underweight | |
| 10/06/2021 | 685.12% | HC Wainwright & Co. | $32 → $19 | Maintains | Buy |
| 10/04/2021 | — | Maxim Group | Downgrades | Buy → Hold | |
| 09/27/2021 | 519.83% | JP Morgan | → $15 | Initiates Coverage On | → Neutral |
| 06/18/2021 | 4032.23% | WBB Securities | $75 → $100 | Maintains | Strong Buy |
| 04/26/2021 | 1222.31% | HC Wainwright & Co. | $34 → $32 | Maintains | Buy |
| 02/01/2021 | 933.06% | UBS | → $25 | Initiates Coverage On | → Buy |
| 01/20/2021 | 1304.96% | HC Wainwright & Co. | $31 → $34 | Maintains | Buy |
| 01/04/2021 | 1180.99% | HC Wainwright & Co. | $32 → $31 | Maintains | Buy |
| 10/20/2020 | 767.77% | B of A Securities | → $21 | Initiates Coverage On | → Buy |
| 09/01/2020 | 395.87% | Wedbush | $17 → $12 | Maintains | Neutral |
| 08/21/2020 | 1222.31% | HC Wainwright & Co. | $34 → $32 | Maintains | Buy |
| 12/02/2019 | 1304.96% | HC Wainwright & Co. | $35 → $34 | Reiterates | → Buy |
| 05/06/2019 | 974.38% | Cantor Fitzgerald | → $26 | Initiates Coverage On | → Overweight |
| 08/10/2018 | 1222.31% | Maxim Group | $25 → $32 | Maintains | Buy |
| 05/17/2018 | 726.45% | Wedbush | $19 → $20 | Maintains | Neutral |
| 03/23/2018 | 933.06% | Maxim Group | $24 → $25 | Maintains | Buy |
| 03/23/2018 | — | Wedbush | Downgrades | Outperform → Neutral | |
| 03/22/2018 | 933.06% | Maxim Group | $24 → $25 | Maintains | Buy |
| 11/08/2017 | 1139.67% | HC Wainwright & Co. | → $30 | Initiates Coverage On | → Buy |
| 11/02/2017 | — | Cowen & Co. | Downgrades | Outperform → Market Perform |
Omeros Questions & Answers
The latest price target for Omeros (NASDAQ: OMER) was reported by B of A Securities on June 8, 2022. The analyst firm set a price target for $4.00 expecting OMER to rise to within 12 months (a possible 65.29% upside). 7 analyst firms have reported ratings in the last year.
The latest analyst rating for Omeros (NASDAQ: OMER) was provided by B of A Securities, and Omeros downgraded their neutral rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Omeros, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Omeros was filed on June 8, 2022 so you should expect the next rating to be made available sometime around June 8, 2023.
While ratings are subjective and will change, the latest Omeros (OMER) rating was a downgraded with a price target of $12.00 to $4.00. The current price Omeros (OMER) is trading at is $2.42, which is out of the analyst's predicted range.